Alonso-Mariño OL, Alonso-Mariño AL

Language: Spanish
References: 11
Page: 1-3
PDF size: 250.78 Kb.

ABSTRACT

Acquired hemophilia A is a rare bleeding disorder characterized by the presence of autoantibodies against circulating factor VIII (FVIII). It has been observed in a heterogeneous group of entities that include, among others, malignant diseases; 32 % associated with urological processes, where prostate cancer has the highest prevalence. We present a patient who was treated at the Oncology Service of the Celestino Hernández Robau University Hospital with the diagnosis of acquired hemophilia A in the course of a prostatic adenocarcinoma. A coagulation study was carried out at the Institute of Hematology and Immunology where the presence of factor VIII inhibitor was confirmed, confirming the diagnosis. Immunosuppressive treatment was given with prednisone 1 mg/kg of weight, with a favorable evolution.

REFERENCES

1. Mingot-Castellano ME, Nuñez R, Rodriguez-Martorell FJ. Hemofilia adquirida: epidemiología, clínica, diagnóstico y tratamiento. Med Clin (Barc).2017;148(7):314-22.

2. Favaloro EJ, Verbruggen B, Millar CH. Laboratory testing for factor inhibitors. Haemophilia.2014;20(suppl 4):94-8.

3. Kessler C M, Knobl P. Acquired haemophilia; an overvieww for clinlcal practice. Eur J Haematol.2015;95(suppl 81):36-44.

4. Tiede A, Amano K, Ma A, Arkhammar P, Fegoun S B, Rosholm A, et al. The use of recombinant activated factor VII in patients with acquired haemophilia. Blood Rev.2015;29(suppl 1):S19 -S25.

5. Zanon E, Milan M, Gamba G, Ambaglio C, Saggiorato G, Spiezia L et al. Activated prothombin complex concentrate (FEIBA) for treatment and prevencion of bleeding in patients with acquired haemophilia: A sequential study. Thromb Res.2015;136:1299 -302.

6. D´Arena G, Grandote E, di Minno MN, Misto P, di Minno G. The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A. Blood Transfus. 2016;14(3):255-61.

7. Zanon E, Milan M. Acquired Hemophilia A: Diagnosis and Management of a Rare Condition associated with A Severe Bleeding Diathesis. J Blood Disord Med. 2016;1(2). doi http://dx.doi. org/10.16966/2471-5026.107

8. Sheth C, Gill A, Sekhon S. Life-threatening hemorrhage from acquired hemophilia A as a presenting manifestation of prostate cancer. J Community Hosp Intern Med Perspect. 2016 Sep 7;6(4):324-61. doi: 10.3402/jchimp.v6.32461.

9. Oh J, Lim Y, Jang MJ, Huh JY, Shima M, Oh D. Characterization of anti-factor VIII antibody in a patient with acquired hemophilia A. Blood Res. 2013;48(1):58-62.

10. Ceresetto JM, Duboscq C, Fondevila C, Tezano M. Hemofilia Adquirida (inhibidor adquirido del factor VIII. Medicina (B Aires). 2015;75(4):231-8.

11. Huth-Kühne A, Baudo F, Collins P, Ingerslev J, Kessler CM, Lévesqueet H, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009;94:566-75.